Due: July 23, 2026
The objective of this RFI is to solicit feedback from industry, academia, and other stakeholders to assist BARDA in understanding the existing capabilities to assume ownership of available equipment and leverage those assets to manufacture an emergency autoinjector platform, featuring a novel glass-free, collapsible, primary drug container (PDC) with the final intent to develop a new drug delivery device or platform.
Responding to this opportunity requires membership in the Biopharmaceutical Manufacturing Preparedness (BioMaP) Consortium. This Consortium releases numerous solicitations throughout the year, so even if this opportunity may not end up being right for you, we strongly encourage you to join, so you are ready for the next opportunity.
Complete the form below and a program representative will reach out to you shortly to support you through the process.